Ethyl 2-chloro-4-(trifluoromethyl)oxazole-5-carboxylate, 97%, 250mg

1,2,4-Trihydroxybenzene>98.0%(GC)10g

3,6,9,12,15,18,21-Heptaoxatritriacontan-1-ol, 98%, 1g

TERT-BUTYL 4-(7-CHLOROQUINOLIN-4-YL)-4-CYANOPIPERIDINE-1-CARBOXYLATE, 95.0%, 100mg

Ethyl 4-chloropyrrolo[2,1-f][1,2,4]triazine-6-carboxylate, 95.0%, 250mg

3,5-Diamino-6-chloropyrazine-2-carboxylic acid, 95.0%, 25g

2-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)thio]acetohydrazide, 250mg

2-Isopropyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.00%, 5g

2-(3-Oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile, 95.0%, 100mg

7-Bromo-5-methoxybenzo[d]thiazol-2-amine, 97%, 250mg

(S)-2-(2-((tert-Butoxycarbonyl)amino)-3-methylbutanamido)acetic acid, 95.0%, 100g

1-Chloro-6-methylisoquinoline, 95.0%, 25g

Cooling box 0 °C for 32 reaction vials (4 x 8), 1 Piece